Covered recipient · General Payments record
SAMEH B ALMADANI
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$4,027.28
- Reported across 226 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $365.13 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $203.21 | 15 |
| AIMMUNE THERAPEUTICS, INC. | $60.57 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $46.63 | 3 |
| GENZYME CORPORATION | $40.60 | 2 |
| Braintree Laboratories, Inc. | $14.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $10.32 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209837 | CMS |
| ABBVIE INC. | $21.43 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209839 | CMS |
| ABBVIE INC. | $13.98 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209841 | CMS |
| ABBVIE INC. | $13.93 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209843 | CMS |
| ABBVIE INC. | $4.06 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209845 | CMS |
| ABBVIE INC. | $15.31 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209847 | CMS |
| ABBVIE INC. | $17.41 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209849 | CMS |
| ABBVIE INC. | $3.13 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209851 | CMS |
| ABBVIE INC. | $22.01 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209853 | CMS |
| ABBVIE INC. | $13.46 | 06/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209855 | CMS |
| ABBVIE INC. | $3.64 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209857 | CMS |
| ABBVIE INC. | $22.82 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209859 | CMS |
| ABBVIE INC. | $10.18 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209861 | CMS |
| ABBVIE INC. | $12.85 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209863 | CMS |
| ABBVIE INC. | $18.68 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103209865 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $17.98 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146982271 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $16.48 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146988311 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $26.11 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147002164 | CMS |
| Braintree Laboratories, Inc. | $14.12 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125512729 | CMS |
| GENZYME CORPORATION | $24.37 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139665710 | CMS |
| GENZYME CORPORATION | $16.23 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139665718 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.09 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137468782 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.72 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137468786 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.82 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137468790 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.